002252 Shanghai RAAS Blood Products
- 6.96
- -0.11-1.56%
Shanghai RAAS Blood Products News
Shanghai Rice: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Shanghai Rice: Announcement on the completion of the non-transactional transfer of the reserved shares of the first phase of the employee stock ownership plan
Shanghai Laishi: Legal Opinion of Beijing Zhonglun (Shanghai) Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Shanghai Laishi Blood Products Co., Ltd.
Shanghai Laishi: Semi-annual non-operating capital usage and other related capital transactions summary table
Shanghai Rice: 2024 Semi-Annual Financial Report
Shanghai Laishi: Semi-Annual Financial Report
Shanghai RAAS Blood Products: Notice on convening the third extraordinary shareholder meeting in 2024.
Shanghai RAAS Blood Products: Announcement Regarding Completion of Board of Directors and Board of Supervisors Election and Appointment of Senior Management Personnel, Securities Affairs Representatives, and Head of Internal Audit Department.
Shanghai RAAS Blood Products: Regulations for the Board of Director's Global Strategy Committee.
Shanghai RAAS Blood Products: Rules of the board of directors' audit committee
Shanghai RAAS Blood Products: Rules for the board of directors' remuneration and assessment committee.
Shanghai RAAS Blood Products: Regulations for the Board of Directors Nomination Committee.
Shanghai RAAS Blood Products: Legal opinion on the second extraordinary general meeting of shareholders of Shanghai RAAS Blood Products Co., Ltd. in 2024.
Shanghai RAAS Blood Products: Notice to creditors regarding the reduction of registered capital due to the cancellation of remaining repurchased shares.
Shanghai RAAS Blood Products: Announcement of the resolution of the second extraordinary general meeting of shareholders in 2024.
Shanghai RAAS Blood Products: Announcement regarding changes of the company's controlling shareholder and actual controller.
Shanghai RAAS Blood Products: Notice on cancellation of remaining repurchased shares, reduction of registered capital, and corresponding amendments to the “Articles of Association”
Shanghai RAAS Blood Products: Announcement on granting reserved shares of the company's first employee stock ownership plan to some employees
Shanghai RAAS Blood Products: Supplementary announcement on the election of the Board of Directors for a new term
Shanghai RAAS Blood Products: Supplementary announcement on the election of the Board of Supervisors for a new term
Analysis
Price Target
No Data
